{"id":"https://openalex.org/W4389619261","doi":"https://doi.org/10.2174/0113816128275084231202153602","title":"Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells","display_name":"Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia Cells","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4389619261","doi":"https://doi.org/10.2174/0113816128275084231202153602","pmid":"https://pubmed.ncbi.nlm.nih.gov/38083885"},"language":"en","primary_location":{"id":"doi:10.2174/0113816128275084231202153602","doi":"https://doi.org/10.2174/0113816128275084231202153602","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0113816128275084231202153602","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007097663","display_name":"\u0416\u0438\u0434\u043a\u043e\u0432\u0430 \u0415\u043a\u0430\u0442\u0435\u0440\u0438\u043d\u0430 \u041c\u0438\u0445\u0430\u0439\u043b\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0003-3318-9391","observed_orcids":["https://orcid.org/0000-0003-3318-9391"]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Zhidkova Ekaterina","raw_affiliation_strings":["Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia"],"raw_orcid":"https://orcid.org/0000-0003-3318-9391","affiliations":[{"raw_affiliation_string":"Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093473560","display_name":"Daria V. Stepanycheva","orcid":"https://orcid.org/0009-0009-0056-6040","observed_orcids":["https://orcid.org/0009-0009-0056-6040"]},"institutions":[{"id":"https://openalex.org/I4210135186","display_name":"MIREA - Russian Technological University","ror":"https://ror.org/04qrtgy16","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210135186"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Stepanycheva Daria","raw_affiliation_strings":["Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia"],"raw_orcid":"https://orcid.org/0009-0009-0056-6040","affiliations":[{"raw_affiliation_string":"Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia","institution_ids":["https://openalex.org/I4210135186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112620889","display_name":"Lyubov E. Grebenkina","orcid":"https://orcid.org/0000-0002-5995-5608","observed_orcids":["https://orcid.org/0000-0002-5995-5608"]},"institutions":[{"id":"https://openalex.org/I4210135186","display_name":"MIREA - Russian Technological University","ror":"https://ror.org/04qrtgy16","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210135186"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Grebenkina Lyubov","raw_affiliation_strings":["Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia"],"raw_orcid":"https://orcid.org/0000-0002-5995-5608","affiliations":[{"raw_affiliation_string":"Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia","institution_ids":["https://openalex.org/I4210135186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004862194","display_name":"Ekaterina A. Mikhina","orcid":"https://orcid.org/0009-0006-2511-3628","observed_orcids":["https://orcid.org/0009-0006-2511-3628"]},"institutions":[{"id":"https://openalex.org/I4210135186","display_name":"MIREA - Russian Technological University","ror":"https://ror.org/04qrtgy16","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210135186"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Mikhina Ekaterina","raw_affiliation_strings":["Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia"],"raw_orcid":"https://orcid.org/0009-0006-2511-3628","affiliations":[{"raw_affiliation_string":"Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia","institution_ids":["https://openalex.org/I4210135186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048947700","display_name":"\u041c\u0430\u043a\u0441\u0438\u043c\u043e\u0432\u0430 \u0412\u0430\u0440\u0432\u0430\u0440\u0430 \u041f\u0430\u0432\u043b\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0003-0896-2952","observed_orcids":["https://orcid.org/0000-0003-0896-2952"]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Maksimova Varvara","raw_affiliation_strings":["Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia"],"raw_orcid":"https://orcid.org/0000-0003-0896-2952","affiliations":[{"raw_affiliation_string":"Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021562631","display_name":"Diana D. Grigoreva","orcid":"https://orcid.org/0000-0003-2675-089X","observed_orcids":["https://orcid.org/0000-0003-2675-089X"]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Grigoreva Diana","raw_affiliation_strings":["Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia"],"raw_orcid":"https://orcid.org/0000-0003-2675-089X","affiliations":[{"raw_affiliation_string":"Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080489737","display_name":"Andrey Valerievich Matveev","orcid":"https://orcid.org/0000-0002-0830-3036","observed_orcids":["https://orcid.org/0000-0002-0830-3036"]},"institutions":[{"id":"https://openalex.org/I4210135186","display_name":"MIREA - Russian Technological University","ror":"https://ror.org/04qrtgy16","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210135186"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Matveev Andrey","raw_affiliation_strings":["Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia"],"raw_orcid":"https://orcid.org/0000-0002-0830-3036","affiliations":[{"raw_affiliation_string":"Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological\nUniversity, 78 Vernadsky Avenue, Moscow 119571, Russia","institution_ids":["https://openalex.org/I4210135186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080490826","display_name":"Ekaterina A. Lesovaya","orcid":"https://orcid.org/0000-0002-1967-9637","observed_orcids":["https://orcid.org/0000-0002-1967-9637"]},"institutions":[{"id":"https://openalex.org/I126527374","display_name":"Peoples' Friendship University of Russia","ror":"https://ror.org/02dn9h927","country_code":"RU","type":"education","lineage":["https://openalex.org/I126527374"]},{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]},{"id":"https://openalex.org/I4210141419","display_name":"Ryazan State Medical University named after Academician I.P. Pavlov","ror":"https://ror.org/04nvcbr70","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210141419"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Lesovaya Ekaterina","raw_affiliation_strings":["Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia","Faculty of Oncology, I.P. Pavlov Ryazan State Medical University,\nMinistry of Health of Russia, 9 Vysokovol\u2019tnaya St., Ryazan 390026, Russia","Laboratory of Single Cell Biology, Friendship University\nof Russia, 6 Miklukho-Maklaya St., Moscow 117198, Russia"],"raw_orcid":"https://orcid.org/0000-0002-1967-9637","affiliations":[{"raw_affiliation_string":"Department of Chemical Carcinogenesis, N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, 24\nKashirskoe Shosse, Moscow 115478, Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]},{"raw_affiliation_string":"Faculty of Oncology, I.P. Pavlov Ryazan State Medical University,\nMinistry of Health of Russia, 9 Vysokovol\u2019tnaya St., Ryazan 390026, Russia","institution_ids":["https://openalex.org/I4210117042","https://openalex.org/I4210141419"]},{"raw_affiliation_string":"Laboratory of Single Cell Biology, Friendship University\nof Russia, 6 Miklukho-Maklaya St., Moscow 117198, Russia","institution_ids":["https://openalex.org/I126527374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5007097663"],"corresponding_institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"],"apc_list":null,"apc_paid":null,"fwci":0.6812,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.55368653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"29","issue":"43","first_page":"3478","last_page":"3487"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.4772999882698059,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.4772999882698059,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.47679999470710754,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/1-2-4-triazole-3-carboxamide","display_name":"1,2,4-triazole-3-carboxamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/tetrahydropyran-derivatives","display_name":"tetrahydropyran derivatives","score":0.8450000286102295},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.5130000114440918},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8629999756813049},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":1.0},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9169999957084656},{"id":"https://openalex.org/keywords/antimetabolites","display_name":"antimetabolites","score":0.7870000004768372},{"id":"https://openalex.org/keywords/anticancer-drug-design","display_name":"anticancer drug design","score":0.5910000205039978},{"id":"https://openalex.org/keywords/parp1-cleavage","display_name":"PARP-1 cleavage","score":0.7229999899864197},{"id":"https://openalex.org/keywords/caspase-3-cleavage","display_name":"caspase-3 cleavage","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C2778327999","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Carboxamide","level":2,"score":0.5550822019577026},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.45496493577957153},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44122081995010376},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.42007747292518616},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4126725494861603},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.41228151321411133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3701406717300415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2964434027671814},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2768951952457428},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1997082233428955},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19681188464164734}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/0113816128275084231202153602","doi":"https://doi.org/10.2174/0113816128275084231202153602","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0113816128275084231202153602","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:38083885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38083885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4090599177","display_name":null,"funder_award_id":"23-25-00382","funder_id":"https://openalex.org/F4320324099","funder_display_name":"Russian Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320324099","display_name":"Russian Science Foundation","ror":"https://ror.org/03y2gwe85"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W92987392","https://openalex.org/W1522110495","https://openalex.org/W1968622004","https://openalex.org/W1980733232","https://openalex.org/W1981461598","https://openalex.org/W1992226313","https://openalex.org/W1995388272","https://openalex.org/W1999390452","https://openalex.org/W2005002555","https://openalex.org/W2007348709","https://openalex.org/W2009348015","https://openalex.org/W2012082047","https://openalex.org/W2013670635","https://openalex.org/W2027355301","https://openalex.org/W2028744406","https://openalex.org/W2047346696","https://openalex.org/W2051674630","https://openalex.org/W2066536862","https://openalex.org/W2066931715","https://openalex.org/W2069641384","https://openalex.org/W2072095756","https://openalex.org/W2075096387","https://openalex.org/W2085664732","https://openalex.org/W2093669458","https://openalex.org/W2108237307","https://openalex.org/W2112519486","https://openalex.org/W2113993278","https://openalex.org/W2128635872","https://openalex.org/W2129587267","https://openalex.org/W2133072023","https://openalex.org/W2136637802","https://openalex.org/W2141988356","https://openalex.org/W2149546612","https://openalex.org/W2169508419","https://openalex.org/W2587512366","https://openalex.org/W2596031164","https://openalex.org/W2597465093","https://openalex.org/W2725970815","https://openalex.org/W2750154792","https://openalex.org/W2760376760","https://openalex.org/W2781832221","https://openalex.org/W2855722286","https://openalex.org/W2898217750","https://openalex.org/W2902454944","https://openalex.org/W2960880420","https://openalex.org/W2972522932","https://openalex.org/W2973061408","https://openalex.org/W2995302866","https://openalex.org/W3033565404","https://openalex.org/W3039457499","https://openalex.org/W3094477132","https://openalex.org/W3129314386","https://openalex.org/W4321788560"],"related_works":["https://openalex.org/W4403318767","https://openalex.org/W4220959814","https://openalex.org/W4289965046","https://openalex.org/W4290375228","https://openalex.org/W7119250085","https://openalex.org/W2756574773","https://openalex.org/W7043569859","https://openalex.org/W3209825463","https://openalex.org/W2508887686","https://openalex.org/W2550792851"],"abstract_inverted_index":{"Background::":[0],"A":[1],"number":[2],"of":[3,8,26,49,56,96,101,121,154,176,196],"studies":[4,175],"demonstrate":[5],"the":[6,24,47,94,108,119,122,150,171,187],"efficacy":[7],"ribavirin":[9,22,35],"against":[10],"various":[11],"cancer":[12,62],"types":[13],"in":[14,15,18,60,64,78,93,159,163,165],"vitro":[16,164],"and":[17,54,72,84,116,132,144,157,202],"vivo":[19],"models.":[20],"However,":[21],"induces":[23],"development":[25],"multiple":[27],"side":[28],"effects,":[29],"suggesting":[30],"a":[31],"high":[32],"demand":[33],"for":[34,142,173],"analogues":[36],"with":[37,129,207],"improved":[38],"therapeutic":[39],"indexes.":[40],"Objective::":[41],"This":[42],"study":[43],"was":[44],"focused":[45],"on":[46],"analysis":[48,141],"ribavirin,":[50],"its":[51,57],"aglycon":[52],"1,2,4-triazole-3-carboxamide,":[53],"several":[55],"derivatives":[58,69,178,189],"activities":[59,193],"blood":[61,98],"cells":[63,82,88,95],"vitro.":[65],"Methods::":[66],"Four":[67],"1,2,4-triazole-3-carboxamide":[68,177,188],"were":[70,76,124,136],"designed":[71],"synthesized.":[73],"Antiproliferative":[74],"effects":[75],"evaluated":[77],"chronic":[79],"myeloid":[80],"leukemia":[81,87,160],"\u041a562":[83],"acute":[85],"lymphoblastic":[86],"CCRF-SB":[89],"as":[90,92,179],"well":[91],"whole":[97],"mononuclear":[99],"fraction":[100],"healthy":[102],"volunteers":[103],"by":[104,126,138,194],"cell":[105,161,197],"counting":[106],"using":[107],"trypan":[109],"blue":[110],"exclusion":[111],"method.":[112],"Cell":[113],"cycle":[114,198],"distribution":[115],"apoptosis":[117,134],"under":[118],"influence":[120],"compounds":[123],"analyzed":[125],"flow":[127],"cytometry":[128],"PI":[130],"staining,":[131],"then":[133],"data":[135],"confirmed":[137],"Western":[139],"blot":[140],"PARP1":[143],"caspase-3":[145],"cleavage.":[146],"Results::":[147],"We":[148],"demonstrated":[149],"significant":[151],"antiproliferative":[152,192],"effect":[153],"5-(tetrahydropyran-2-yl)-1,2,4-triazole-3-":[155],"carboxamide":[156],"1-(tetrahydropyran-2-yl)-1,2,4-triazol-3-carboxamide":[158],"lines":[162],"comparison":[166],"to":[167],"non-transformed":[168],"monocytes,":[169],"providing":[170],"rationale":[172],"further":[174],"anti-leukemia":[180],"drugs.":[181],"Conclusion::":[182],"These":[183],"results":[184],"implied":[185],"that":[186],"exhibited":[190],"their":[191],"induction":[195],"arrest.":[199],"Consequently,":[200],"5-(tetrahydropyran-2-yl)-1,2,4-triazole-3-carboxamide":[201],"1-(tetrahydrofuran-2-yl)-1,2,4-triazol-3-carboxamide":[203],"may":[204],"present":[205],"antimetabolites":[206],"potential":[208],"anticancer":[209],"efficacy.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-13T00:00:00"}